Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica · 2026
Remnant kidney volume-to-weight ratio and point score predict post-donor kidney function: the hypertrophy paradox and structure-demand model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
El Hennawy Hany M, Safar Omar, Tawhari Ibrahim, Asiri Aisha Jaber, Alshahrani Ali Thamer, Alshahrani Fahad Shari, Alobaid Mohammed Hassan, Laghbi Abdullah, Aboalsamh Ghaleb A, Jaber Tariq, El Hennawy Menna, Khedr Abdullah, Ibrahim Mona, Bazeed Mohammed F
Аннотация
BACKGROUND: Most living kidney donors recover 60-70% of baseline renal function, yet some show suboptimal compensation despite a favorable baseline eGFr. The remnant kidney volume to weight ratio (rKV/w) reflects anatomical reserve relative to metabolic demand, but its predictive value has not been tested in Middle eastern populations, and it is unknown whether volumetric hypertrophy guarantees functional gain.
METHODS: we retrospectively analyzed 368 living kidney donors who underwent left sided laparoendoscopic single site nephrectomy (2017-2024). Preoperative CT volumetry measured rKV/w. suboptimal recovery was defined as eGFr < 60% of baseline at 1 year. Multivariate logistic regression, roC analysis, and a point score were developed. In 124 donors with follow up imaging, we compared compensatory hypertrophy (percent volume increase) between recovery groups.
RESULTS: suboptimal recovery occurred in 38 donors (10.3%). rKV/w independently predicted suboptimal recovery (adjusted or 2.94; 95% CI 1.85-4.67; p < 0.001). A threshold of 2.2 mL/kg yielded 84.2% sensitivity and 76.1% specificity (AUC for rKV/w alone 0.82). rKV/w correlated modestly with MAG3 split function (rho = 0.31; 95% CI 0.20-0.41). A 4 item point score (age ≥ 35, BMI ≥ 27, baseline eGFr ≥ 95, rKV/w < 2.2) achieved an AUC of 0.84. Novel finding: compensatory hypertrophy was similar between groups (18.2% vs 19.5% volume increase, p = 0.52), yet functional recovery differed significantly, a "hypertrophy paradox."
CONCLUSIONS: rKV/w independently predicts post donation functional compensation, supporting a structure-demand model. The hypertrophy paradox challenges the assumption that an increase in volume alone equates to adaptation. The 2.2 mL/kg threshold and point score (AUC 0.84) offer practical risk stratification tools, but external validation is required before clinical use.
METHODS: we retrospectively analyzed 368 living kidney donors who underwent left sided laparoendoscopic single site nephrectomy (2017-2024). Preoperative CT volumetry measured rKV/w. suboptimal recovery was defined as eGFr < 60% of baseline at 1 year. Multivariate logistic regression, roC analysis, and a point score were developed. In 124 donors with follow up imaging, we compared compensatory hypertrophy (percent volume increase) between recovery groups.
RESULTS: suboptimal recovery occurred in 38 donors (10.3%). rKV/w independently predicted suboptimal recovery (adjusted or 2.94; 95% CI 1.85-4.67; p < 0.001). A threshold of 2.2 mL/kg yielded 84.2% sensitivity and 76.1% specificity (AUC for rKV/w alone 0.82). rKV/w correlated modestly with MAG3 split function (rho = 0.31; 95% CI 0.20-0.41). A 4 item point score (age ≥ 35, BMI ≥ 27, baseline eGFr ≥ 95, rKV/w < 2.2) achieved an AUC of 0.84. Novel finding: compensatory hypertrophy was similar between groups (18.2% vs 19.5% volume increase, p = 0.52), yet functional recovery differed significantly, a "hypertrophy paradox."
CONCLUSIONS: rKV/w independently predicts post donation functional compensation, supporting a structure-demand model. The hypertrophy paradox challenges the assumption that an increase in volume alone equates to adaptation. The 2.2 mL/kg threshold and point score (AUC 0.84) offer practical risk stratification tools, but external validation is required before clinical use.